Cargando…
Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects
BACKGROUND: Transcutaneous neurostimulation (TNS) at extracephalic sites is a well known treatment of pain. Thanks to recent technical progress, the Cefaly(® )device now also allows supraorbital TNS. During observational clinical studies, several patients reported decreased vigilance or even sleepin...
Autores principales: | Piquet, Maxime, Balestra, Costantino, Sava, Simona L, Schoenen, Jean E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261828/ https://www.ncbi.nlm.nih.gov/pubmed/22035386 http://dx.doi.org/10.1186/1471-2377-11-135 |
Ejemplares similares
-
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
por: Magis, Delphine, et al.
Publicado: (2013) -
Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device (PREMICE): a multi-centre, randomized, sham-controlled trial
por: Schoenen, J, et al.
Publicado: (2013) -
Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
por: Russo, Antonio, et al.
Publicado: (2015) -
Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly(®) Device for Migraine Prevention: A Review of the Available Data
por: Riederer, Franz, et al.
Publicado: (2015) -
P019. Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
por: Russo, Antonio, et al.
Publicado: (2015)